参考文献/References:
[1]Rezzonico J,Rezzonico M,Pusiol E,et al.Introducing the thyroid gland as another victim of the insulin resistance syndrome[J].Thyroid,2008,18(4):461-464.[2]Guo W,Tan L,Chen W,et al.Relationship between metabolic syndrome and thyroid nodules and thyroid volume in an adult population[J].Endocrine,2019,65(2):357-364.[3]Xiao Y,Mao J,Mao X,et al.Metabolic syndrome and its components are associated with thyroid volume in adolescents[J].BMC Endocr Disord,2021,21(1):176.[4]孙荣欣,郑召辉,张强,等.人群体质量指数与甲状腺结节患病率及其恶性风险分层的相关性[J].川北医学院学报,2021,36(1):72-75.[5]贾晓蒙,姜丽娜,庞萍,等.抗甲状腺球蛋白抗体与女性甲状腺乳头状癌患病风险的相关性[J].中华内分泌代谢杂志,2019,35(8):685-689.[6]Liang Q,Yu S,Chen S,et al.Association of Changes in Metabolic Syndrome Status With the Incidence of Thyroid Nodules: A Prospective Study in Chinese Adults[J].Front Endocrinol (Lausanne),2020,11:582.[7]Nduka CC,Adeyekun AA.Ultrasound assessment of thyroid gland volume in diabetic patients without overt thyroid disease[J].Ann Afr Med,2016,15(4):157-162.[8]王晓艳,王亚军,蒿花,等.甲状腺结节与代谢综合征相关组分的临床研究[J].西安交通大学学报(医学版),2017,38(1):151-153. [9]张春玉,曾洪利,刘颖,等.甲状腺结节与代谢综合征及其组分的相关性分析[J].中华内分泌代谢杂志,2012,28(2):132-135.[10]Su Y,Zhang YL,Zhao M,et al.Association Between Thyroid Nodules and Volume and Metabolic Syndrome in an Iodine-Adequate Area: A Large Community-Based Population Study[J].Metab Syndr Relat Disord,2019,17(4):217-222. [11]Mayers RA,Soria Montoya A,Piscoya Rivera A,et al.Association between metabolic syndrome and euthyroid nodular goiter:a case-control study[J].Colomb Med (Cali),2019,50(4):239-251. [12]Liu J,Wang C,Tang X,et al.Correlation analysis of metabolic syndrome and its components with thyroid nodules[J].Diabetes Metab Syndr Obes,2019,12:1617-1623.[13]Haroon SM,Khan K,Maqsood M,et al.Exploring the Effect of Metformin to Lower Thyroid-Stimulating Hormone in Euthyroid and Hypothyroid Type-2 Diabetic Patients[J].Cureus,2021,13(2):e13283.[14]He X,Wu D,Hu C,et al.Role of Metformin in the Treatment of Patients with Thyroid Nodules and Insulin Resistance: A Systematic Review and Meta-Analysis[J].Thyroid,2019,29(3):359-367.[15]Ayturk S,Gursoy A,Kut A,et al.Metabolic syndrome and its components are associated with increased thyroid volume and nodule prevalence in a mild-to-moderate iodine-deficient area[J].Eur J Endocrinol,2009,161(4):599-605.[16]Petersen MC,Shulman GI.Mechanisms of Insulin Action and Insulin Resistance[J].Physiol Rev,2018,98(4):2133-2223.[17]Tsatsoulis A,Mantzaris MD,Bellou S,et al.Insulin resistance: an adaptive mechanism becomes maladaptive in the current environment-an evolutionary perspective[J].Metabolism,2013,62(5):622-633. [18]Bidey SP,Hill DJ,Eggo MC.Growth factors and goitrogenesis[J].J Endocrinol,1999,160(3):321-332. [19]Malaguarnera R,Morcavallo A,Belfiore A.The insulin and igf-I pathway in endocrine glands carcinogenesis[J].J Oncol,2012,2012:635614.[20]Malaguarnera R,Frasca F,Garozzo A,et al.Insulin receptor isoforms and insulin-like growth factor receptor in human follicular cell precursors from papillary thyroid cancer and normal thyroid[J].J Clin Endocrinol Metab,2011,96(3):766-764. [21]Campbell I,Campbell H.Mechanisms of insulin resistance, mitochondrial dysfunction and the action of the ketogenic diet in bipolar disorder. Focus on the PI3K/AKT/HIF1-a pathway[J].Med Hypotheses,2020,145:110299.[22]Lawan A,Min K,Zhang L,et al.Skeletal Muscle-Specific Deletion of MKP-1 Reveals a p38 MAPK/JNK/Akt Signaling Node That Regulates Obesity-Induced Insulin Resistance[J].Diabetes,2018,67(4):624-635. [23]Yang L,Tan Z,Li Y,et al.Insulin-like growth factor 1 promotes proliferation and invasion of papillary thyroid cancer through the STAT3 pathway[J].J Clin Lab Anal,2020,34(12):e23531.[24]Smith TJ.Insulin-Like Growth Factor Pathway and the Thyroid[J].Front Endocrinol (Lausanne),2021,12:653627.[25]Smith TJ.The insulin-like growth factor-I receptor and its role in thyroid-associated ophthalmopathy[J].Eye(Lond),2019,33(2):200-205.[26]Ittermann T,Schipf S,Dorr M,et al.Hyperthyroxinemia is positively associated with prevalent and incident type 2 diabetes mellitus in two population-based samples from Northeast Germany and Denmark[J].Nutr Metab Cardiovasc Dis,2018,28(2):173-179.[27]Quinn M,Bashari W,Smith D,et al.A remarkable case of thyrotoxicosis initially caused by graves’ disease followed by a probable TSHoma - a case report[J].BMC Endocr Disord,2020,20(1):133.[28]Zsarnovszky A,Kiss D,Jocsak G,et al.Thyroid hormone- and estrogen receptor interactions with natural ligands and endocrine disruptors in the cerebellum[J].Front Neuroendocrinol,2018,48:23-36.[29]Xu LW,Zhang LY,Gou X,et al.Effects of UHRF1 on Estrogen Receptor and Proliferation, Invasion and Migration of BCPAP Cells in Thyroid Papillary Carcinoma[J].Journal of Sichuan University(Medical Sciences),2020,51(3):325-330.[30]Chen Y,Chen Y,Wang N,et al.Are thyroid nodules associated with sex-related hormones?A cross-sectional SPECT-China study[J].BMJ Open,2017,7(8):e015812.[31]Corona G,Monami M,Rastrelli G,et al.Testosterone and metabolic syndrome: a meta-analysis study[J].J Sex Med,2011,8(1):272-283. [32]Brand JS,Rovers MM,Yeap BB,et al.Testosterone, sex hormone-binding globulin and the metabolic syndrome in men: an individual participant data meta-analysis of observational studies[J].PLoS One,2014,9(7):e100409. [33]Guo Q,Chang B,Yu QL,et al.Adiponectin treatment improves insulin resistance in mice by regulating the expression of the mitochondrial-derived peptide MOTS-c and its response to exercise via APPL1-SIRT1-PGC-1α[J].Diabetologia,2020,63(12):2675-2688.[34]Wang SJ,Wang C,Wang WQ,et al.Adiponectin Receptor Agonist AdipoRon Inhibits the Proliferation of Myeloma Cells via the AMPK/Autophagy Pathway[J].Journal of Experimental Hematology,2020,28(1):171-176.[35]Briansó-Llort L,Fuertes-Rioja L,Ramos-Perez L,et al.Caffeine Upregulates Hepatic Sex Hormone-Binding Globulin Production by Increasing Adiponectin Through AKT/FOXO1 Pathway in White Adipose Tissue[J].Mol Nutr Food Res,2020,64(17):e1901253.
相似文献/References:
[1]靳雪芹,邓正聪.代谢综合征与肿瘤关系的研究进展[J].医学信息,2018,31(05):35.[doi:10.3969/j.issn.1006-1959.2018.05.014]
JIN Xue-qin,DENG Zheng-cong.Research Progress on the Relationship between Metabolic Syndrome and Tumor[J].Medical Information,2018,31(14):35.[doi:10.3969/j.issn.1006-1959.2018.05.014]
[2]龙 颖,李运泽,汤中敏,等.非酒精性脂肪性肝病与血尿酸水平测定及其临床意义[J].医学信息,2018,31(07):92.[doi:10.3969/j.issn.1006-1959.2018.07.029]
LONG Ying,LI Yun-ze,TANG Zhong-min,et al.Determination of Serum Uric Acid Level and its Clinical Significance in Non-alcoholic Fatty Liver Disease[J].Medical Information,2018,31(14):92.[doi:10.3969/j.issn.1006-1959.2018.07.029]
[3]杨锦龙,刘 欢,吕秋菊,等.非糖尿病患者糖化血红蛋白和胰岛素抵抗与
冠状动脉病变程度的相关性研究[J].医学信息,2018,31(10):93.[doi:10.3969/j.issn.1006-1959.2018.10.028]
YANG Jin-long,LIU Huan,LV Qiu-ju,et al.Correlation between Glycosylated Hemoglobin and Insulin Resistance and Severity of Coronary Artery Disease in Non-diabetic Patients[J].Medical Information,2018,31(14):93.[doi:10.3969/j.issn.1006-1959.2018.10.028]
[4]崔姗姗,刘 英,江 霞.非酒精性脂肪性肝病与胰岛素抵抗的研究进展[J].医学信息,2022,35(10):66.[doi:10.3969/j.issn.1006-1959.2022.10.016]
CUI Shan-shan,LIU Ying,JIANG Xia.Research Progress on Non-alcoholic Fatty Liver Disease and Insulin Resistance[J].Medical Information,2022,35(14):66.[doi:10.3969/j.issn.1006-1959.2022.10.016]
[5]何 丽.应激性高血糖与急性心肌梗死的机制研究[J].医学信息,2022,35(10):74.[doi:10.3969/j.issn.1006-1959.2022.10.018]
HE Li.Mechanism of Stress Hyperglycemia and Acute Myocardial Infarction[J].Medical Information,2022,35(14):74.[doi:10.3969/j.issn.1006-1959.2022.10.018]
[6]陈 丽,郝丽娟.多囊卵巢综合征患者腹型肥胖、高雄、胰岛素抵抗及脂代谢的相关性分析[J].医学信息,2022,35(12):113.[doi:10.3969/j.issn.1006-1959.2022.12.027]
CHEN Li,HAO Li-juan.Correlation of Abdominal Obesity, Hyperandrogenism, Insulin Resistance and Lipid Metabolism in Patients with Polycystic Ovary Syndrome[J].Medical Information,2022,35(14):113.[doi:10.3969/j.issn.1006-1959.2022.12.027]
[7]薛 瑶,高 妮,高 逍,等.榆林市职业人群代谢综合征的患病情况及影响因素[J].医学信息,2022,35(13):7.[doi:10.3969/j.issn.1006-1959.2022.13.002]
XUE Yao,GAO Ni,GAO Xiao,et al.Prevalence and Influencing Factors of Metabolic Syndrome Among Occupational Population in Yulin[J].Medical Information,2022,35(14):7.[doi:10.3969/j.issn.1006-1959.2022.13.002]
[8]谢小莉,李 燕,霍 敏,等.老年2型糖尿病患者轻度认知功能障碍与胰岛素抵抗、
白介素-6的相关性研究[J].医学信息,2019,32(15):97.[doi:10.3969/j.issn.1006-1959.2019.15.030]
XIE Xiao-li,LI Yan,HUO Min,et al.Correlation between Mild Cognitive Impairment and Insulin Resistance and
Interleukin-6 in Elderly Type 2 Diabetic Patients[J].Medical Information,2019,32(14):97.[doi:10.3969/j.issn.1006-1959.2019.15.030]
[9]赵 猛,孙 娟,褚 璇.苯扎贝特改善2型糖尿病合并高甘油三酯血症患者
胰岛素抵抗的临床分析[J].医学信息,2019,32(17):145.[doi:10.3969/j.issn.1006-1959.2019.17.048]
ZHAO Meng,SUN Juan,CHU Xuan.Clinical Analysis of Bezafibrate in Improving Insulin Resistance in Patients with
Type 2 Diabetes Mellitus Complicated with Hypertriglyceridemia[J].Medical Information,2019,32(14):145.[doi:10.3969/j.issn.1006-1959.2019.17.048]
[10]符春辉,廖金平,李秋实.老年2型糖尿病患者血清GGT、RBP4水平与代谢综合征发生的相关性研究[J].医学信息,2022,35(15):83.[doi:10.3969/j.issn.1006-1959.2022.15.018]
FU Chun-hui,LIAO Jin-ping,LI Qiu-shi.Correlation Between Serum GGT, RBP4 Levels and Metabolic Syndrome in Elderly Patients with Type 2 Diabetes Mellitus[J].Medical Information,2022,35(14):83.[doi:10.3969/j.issn.1006-1959.2022.15.018]
[11]吕 宁,徐 昕,黄 永,等.公安民警皮肤软纤维瘤与代谢综合征危险因素相关性研究[J].医学信息,2018,31(10):69.[doi:10.3969/j.issn.1006-1959.2018.10.021]
LV Ning,XU Xin,HUANG Yong,et al.Correlative Study on Skin Soft Fibroma and Risk Factors of Metabolic Syndrome in Public Security Police[J].Medical Information,2018,31(14):69.[doi:10.3969/j.issn.1006-1959.2018.10.021]
[12]刘柏基,熊波波.代谢综合征与良性前列腺增生合并下尿路症状的关系
及治疗研究[J].医学信息,2019,32(17):28.[doi:10.3969/j.issn.1006-1959.2019.17.010]
LIU Bai-ji,XIONG Bo-bo.Relationship between Metabolic Syndrome and Benign Prostatic Hyperplasia with
Lower Urinary Tract Symptoms and Treatment[J].Medical Information,2019,32(14):28.[doi:10.3969/j.issn.1006-1959.2019.17.010]